Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Hepatol. Jul 27, 2024; 16(7): 995-1008
Published online Jul 27, 2024. doi: 10.4254/wjh.v16.i7.995
Table 4 Baseline biochemical, serologic, and virological data of patients with chronic hepatitis B, by cirrhosis status, Harar, Eastern Ethiopia
Variables
All patients, n = 193No cirrhosis, n = 133Cirrhosis, n = 60P value
WBC as 106/L5.9 (4.1-7.7)6.5 (4.9-7.8)4.2 (3.0-6.3)<0.001a
Hemoglobin in g/L14.7 (12.4-16.6)15.5 (13.8-16.9)11.8 (10.0-15.2)< 0.001a
Platelet count as 109/L1<0.001a
    Median (IQR)218 (119-294)253 (184-344)118 (54-180.3)
    < 150, n (%)60 (32.1)20 (15.7)40 (66.7)
    ≥ 150, n (%)127 (67.9)107 (84.3)20 (33.3)
ALT (U/L)20.033a
    Median (IQR)36 (23-58)35 (22-52)45 (27-84)
    < 40, n (%)96 (52.5)70 (55.6)26 (45.6)
    ≥ 40, n (%)87 (47.5)56 (44.4)31 (54.4)
AST as IU/L30.016a
    Median (IQR)40 (29-65)36 (28-57)51 (34-81)
    < 40, n (%)90 (49.5)67 (53.6)23 (40.4)
    ≥ 40, n (%)92 (50.5)58 (46.4)34 (59.6)
Creatinine in mg/dL40.750
    Median (IQR)0.8 (0.6-1.0)0.8 (0.6-1.0)0.8 (0.6-1.0)
    ≤ 1.2, n (%)150 (90.4)101 (91.0)49 (89.1)
    > 1.2, n (%)16 (9.6)10 (9.0)6 (10.9)
APRI score5< 0.001a
    Median (IQR)0.52 (0.29-1.35)0.38 (0.26-0.70)1.53 (0.66-2.84)
    < 1.5, n (%)136 (77.7)108 (91.5)28 (49.1)
    ≥ 1.5, n (%)39 (22.3)10 (8.5)29 (50.9)
FIB-4 score6< 0.001a
    Median (IQR)1.06 (0.60-1.98)0.85 (0.55-1.41)1.93 (1.03-4.08)
    ≤ 3.25, n (%)142 (82.6)106 (90.6)36 (65.5)
    > 3.25, n (%)30 (17.4)11 (9.4)19 (34.5)
HBeAg70.001a
    Negative, n (%)105 (78.9)80 (87.9)25 (59.5)
    Positive, n (%)28 (21.1)11 (12.8)17 (40.5)
HBV viral load in IU/mL8< 0.001a
    Median (IQR)677 (135-7580)486 (105-2863)2843 (313-805407)
    < 2000, n (%)114 (64.4)91 (72.2)23 (45.1)
    2000-19999, n (%)24 (13.6)15 (11.9)9 (17.6)
    ≥ 20000, n (%)39 (22.0)20 (15.9)19 (37.3)